via CCSVI Australia -IMPORTANT INFORMATION for people with CCSVI!: “The FDA warns caution in the use of Gilenya by persons who have cardiovascular disease in addition to MS. If you have CCSVI - you should read this. Helen” http://www.theheart.org/article/1398805.do


MS drug fingolimod gets CVD warnings | theheart.org
www.theheart.org
The agency completed review of a patient death after the first dose of fingolimod and has updated contraindications and monitoring recommendations for patients with multiple sclerosis.